Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Children Are Not Small Adults: Specific Findings in Statin Exposure and Response in a Growing Population.

Literature DB >> 30970165

Children Are Not Small Adults: Specific Findings in Statin Exposure and Response in a Growing Population.

Jonathan B Wagner^1,2,3.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2019 PMID： 30970165 PMCID： PMC6663579 DOI： 10.1002/cpt.1431

Source DB: PubMed Journal: Clin Pharmacol Ther ISSN： 0009-9236 Impact factor: 6.875

× No keyword cloud information.

7 in total

1. Impact of SLCO1B1 Genotype on Pediatric Simvastatin Acid Pharmacokinetics.

Authors: Jonathan B Wagner; Susan Abdel-Rahman; Leon Van Haandel; Andrea Gaedigk; Roger Gaedigk; Geetha Raghuveer; Ralph Kauffman; J Steven Leeder
Journal: J Clin Pharmacol Date: 2018-02-22 Impact factor: 3.126

2. HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism.

Authors: Chi-Yi Yu; Elizabeth Theusch; Kathleen Lo; Lara M Mangravite; Devesh Naidoo; Mariya Kutilova; Marisa W Medina
Journal: Hum Mol Genet Date: 2013-09-02 Impact factor: 6.150

3. Impact of Genetic Variation on Pravastatin Systemic Exposure in Pediatric Hypercholesterolemia.

Authors: Jonathan B Wagner; Susan Abdel-Rahman; Roger Gaedigk; Andrea Gaedigk; Geetha Raghuveer; Vincent S Staggs; Ralph Kauffman; Leon Van Haandel; J Steven Leeder
Journal: Clin Pharmacol Ther Date: 2019-02-25 Impact factor: 6.875

4. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.

Authors: Marja K Pasanen; Mikko Neuvonen; Pertti J Neuvonen; Mikko Niemi
Journal: Pharmacogenet Genomics Date: 2006-12 Impact factor: 2.089

5. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).

Authors: Mikko Niemi; Elke Schaeffeler; Thomas Lang; Martin F Fromm; Mikko Neuvonen; Carl Kyrklund; Janne T Backman; Reinhold Kerb; Matthias Schwab; Pertti J Neuvonen; Michel Eichelbaum; Kari T Kivistö
Journal: Pharmacogenetics Date: 2004-07

6. The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

Authors: L B Ramsey; S G Johnson; K E Caudle; C E Haidar; D Voora; R A Wilke; W D Maxwell; H L McLeod; R M Krauss; D M Roden; Q Feng; R M Cooper-DeHoff; L Gong; T E Klein; M Wadelius; M Niemi
Journal: Clin Pharmacol Ther Date: 2014-06-11 Impact factor: 6.875

7. Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.

Authors: B Prasad; A Gaedigk; M Vrana; R Gaedigk; J S Leeder; L Salphati; X Chu; G Xiao; Ceca Hop; R Evers; L Gan; J D Unadkat
Journal: Clin Pharmacol Ther Date: 2016-08-13 Impact factor: 6.875

7 in total

3 in total